Considering theobtained results, the current study has identified a series of leadmolecules as multitarget inhibitors of AR and α-GLY for advancedresearch in order to obtain drugs to be used in the treatment of diabetes. This evidence concerns the gene SHMT2 and diabetes mellitus.